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ABSTRACT 27 
The osteoporosis-resistant nature of skull bones implies inherent differences exist between their 28 
cellular responses and those of other osteoporosis-susceptible skeletal sites. Phenotypic differences in 29 
calvarial and femoral osteoblastic responses to induction of osteogenesis, mechanical loading, 30 
estrogen, growth factor and cytokine stimulation were investigated.  31 
 32 
Primary rat calvarial and femoral adult male osteoblasts were cultured and osteoblastic mineralisation 33 
and maturation determined using Alizarin Red staining and expression of osteogenic marker genes 34 
assessed. Expression of known mechanically-responsive genes was compared between sites following 35 
loading of scaffold-seeded cells in a bioreactor. Cell proliferation and differentiation following growth 36 
factor and estrogen stimulation were also compared. Finally expression of estrogen receptors and 37 
associated genes during osteogenic differentiation were investigated. 38 
 39 
Calvarial osteoblasts exhibited delayed maturation (45d. vs 21d.) and produced less mineralised matrix 40 
than femoral osteoblasts when osteogenically induced. PDGF-BB and FGF2 both caused a selective 41 
increase in proliferation and decrease in osteoblastic differentiation of femoral osteoblasts. Mechanical 42 
stimulation resulted in the induction of the expression of Ccl2 and Anx2a selectively in femoral 43 
osteoblasts, but remained unchanged in calvarial cells. Estrogen receptor beta expression was 44 
selectively upregulated 2-fold in calvarial osteoblasts. Most interestingly, the estrogen responsive 45 
transcriptional repressor RERG was constitutively expressed at 1000-fold greater levels in calvarial 46 
compared with femoral osteoblasts.  RERG expression in calvarial osteoblasts was down regulated 47 
during osteogenic induction whereas upregulation occurred in femoral osteoblasts.  48 
 49 
Bone cells of the skull are inherently different to those of the femur, and respond differentially to a 50 
range of stimuli. These site-specific differences may have important relevance in the development of 51 
strategies to tackle metabolic bone disorders. 52 
  53 
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INTRODUCTION 54 
Osteoporosis occurs as the result of an imbalance in bone remodelling predominately in the 55 
appendicular and vertebral skeleton such that bone resorption exceeds bone formation and is most 56 
obvious in post-menopausal women with relative estrogen deficiency, in men with reduced androgen 57 
levels, and with decreased levels of physical activity1. Paradoxically, the skull bones retain structural 58 
integrity despite low levels of mechanical loading, and furthermore, they are essentially unaffected by 59 
osteoporosis2,3. That not all bones are equally susceptible to the condition implies inherent differences 60 
in the resident bone cells, potentially dependent on their position in the body.  61 
The reasons for these differences in susceptibility to metabolic and disuse osteoporosis are not fully 62 
understood, and could be dependent differences between intramembranous (calvarial) versus 63 
endochondral (limb) primary ossification processes. Contrary to this, primary ossification of the lateral 64 
aspect of the clavicle is intramembranous, yet it is this aspect that is more prone to osteoporosis 65 
compared with the medial endochondral-derived aspect4. What is common, however, is that the medial 66 
aspect of the clavicle and skull bones contain neural crest-derived cells5. Previous studies have also 67 
shown differences in proliferation, osteogenic differentiation and response to growth factors between 68 
neural crest dual intramembranous-endochondral-derived orofacial and mesodermal endochondral-69 
derived appendicular bones6,7. Thus differences may not be solely determined by the mechanism of 70 
bone formation or turnover per se, but also possibly by differential regulation of bone formation in 71 
distinct sites – in this case an intramembranous-derived calvarial bone with a neural crest component 72 
compared with an endochondral-derived bone with no neural crest component. 73 
As well distinct formation processes, numerous studies have also shown physical and functional 74 
differences between osteoclasts derived from appendicular and calvarial sites both in vitro and in vivo 75 
which could impact on the susceptibility of individual bones to osteoporosis 8-11. In addition both 76 
matrix composition12,13 and osteocyte morphology14 have been shown to differ between calvaria and 77 
long bones. These differences may be related to features of site-related osteoblastic heterogeneity 78 
including sensitivity to PTH15 as well as induction of osteoclastogenesis and levels of signalling 79 
pathway genes involved in osteoclast formation16.   80 
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It has become increasingly clear that defined mature cell phenotypes may in fact show much greater 81 
diversity than perhaps has been traditionally conceived and understood 17,18.  In a previous study from 82 
our group we investigated differences in global gene expression patterns between adult rodent long 83 
bones and skull bones and matched pairs of isolated osteoblasts derived from femurs and calvaria in 84 
vitro.  In the isolated bone cells we found 246 differentially expressed genes between osteoblasts from 85 
these sources 19. Prominent amongst differentially expressed genes were genes associated with cell 86 
embryonic origin such as homeobox containing genes (Hoxa, Hoxb, Hoxc, Hoxd, Shox) and other 87 
transcription factors which are thought to act specifically on embryologically distinct bone formation.  88 
These include Msx-2, Dlx-5 and Cart1 whose disruption in knock out mice specifically affects cranial 89 
bone formation and Tbx-3 which specifically affects limb bone formation19.  Furthermore, in 90 
experiments described by Leucht and co-workers, mandibular Hoxa –ve and femoral Hoxa+ve 91 
osteogenic stem cells were tested for their ability to contribute to healing in mandibular and femoral 92 
bone defects in vivo.  They demonstrated that Hoxa +ve cells were unable to contribute to healing in 93 
the mandibular site, but Hoxa –ve cells contributed to wound healing in the femoral site 20. Taken 94 
together the data suggest the hypothesis that regionally specific osteoblasts are phenotypically distinct, 95 
due to cell autonomous mechanisms. That osteoblasts have “positional memory” such that the 96 
localised information they express during embryogenesis persists into the adult organism results in 97 
regionally specified differences in osteoblast phenotypes, and further, that these differences translate 98 
to functional physiological responses controlling bone homeostasis. Here we studied the phenotypic 99 
differences in adult-derived calvarial and femoral osteoblast responses to the induction of 100 
osteogenesis, mechanical loading, estrogen, growth factor and cytokine stimulation. Adult derived 101 
rodent calvarial cells have reduced proliferation, mineralisation, and growth factor responsiveness 102 
when compared to juvenile osteoblasts21. Therefore it appears that these altered characteristics make 103 
them more suitable to investigate in this context. 104 
Cellular responses to estrogen stimulation are dependent on expression of Estrogen receptors (ER) 105 
which may alter markedly according to the stage of cell differentiation.  Estrogen receptors are nuclear 106 
receptors which consist of 2 isoforms, ERα and ERß, which have distinct expression patterns and may 107 
have distinct functions1.   In addition their function may be regulated particularly by specific co-108 
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regulators either as receptor co-activators such as the SRCs, and receptor co-repressors such as the N-109 
CoRs and rerg1.  110 
Despite these previous findings more systematic studies are required to elucidate the differences 111 
between mature skull and limb bone derived osteoblasts from to further recognise potential strategies 112 
to treat osteoporosis. Therefore, the aim of the study here was to investigate the hypothesis that there 113 
are intrinsic differences in expression of genes involved in the estrogen signal cascade between adult-114 
derived calvarial and femoral osteoblasts. It is proposed that the results of these experiments may 115 
contribute to identification of potential signalling targets responsible for distinct behaviour of 116 
positionally distinct osteoblast populations.  117 
 118 
 119 
 120 
  121 
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MATERIALS AND METHODS 122 
Cell culture 123 
All animal protocols were in accordance with the UK Home Office Scientific Procedures Act (1986). 124 
Male Wistar rats (210 g, 10 weeks old) were purchased from Charles River, housed, and fed ad 125 
libitum in accordance with local Queen Mary University of London, School of Medicine and Dentistry 126 
rules and sacrificed by cervical dislocation. Calvarial and femoral bones were aseptically removed, 127 
cleared of soft tissues and cut into pieces. The bone chips were transferred evenly into 6-well culture 128 
plates containing DMEM supplemented with 10% fetal bovine serum with glutamine  (2 mM) and 1% 129 
P/S and incubated at 37oC in 5% CO2 incubator, left undisturbed for 48-72 hours until an ‘osteoid 130 
seam’ was noticed. When adherent cells of seam formation were observed, the bone chips were 131 
collected and bone cells isolated by enzymatic digestion. Osteoblasts were cultured in α-MEM without  132 
ribo/deoxyribonucleosides, L-glutamine (2 mM), penicillin (50 U/mL), streptomycin (50 µg/mL) 133 
and 10% fetal bovine serum (FBS) (all from Sigma–Aldrich) and media was replenished every 3-4 134 
days. To stimulate osteogenesis cells were treated with medium supplemented with 0.1µM 135 
dexamethasone, 0.05mM Ascorbic Acid (AA) and 5mM β-glycerophosphate (all from Sigma–136 
Aldrich). To assess osteogenic differentiation, mRNA expression of markers of differentiation (i.e. 137 
Runx-2, ALPL, osteopontin and osteocalcin) was determined by quantitative (q)RT-PCR and 138 
accumulation of calcium deposits was visualised and quantified by staining with Alizarin Red dye.  139 
Briefly, cells were fixed (15 min. with 4% formaldehyde in PBS), stained for 10 min with Alizarin 140 
Red S (1:100 dilution in H2O) and washed in 50% ethanol and air-dried. Cell cultures were stimulated 141 
with the following recombinant growth factors and cytokines FGF-2 (10ng/ml) (Peprotech, London, 142 
UK), PDGF-BB (10ng/ml) (Peprotech), BMP2 (100ng/ml) and Wnt3a (50ng/ml) (both from R&D 143 
systems), as well as β-estradiol (Sigma-Aldrich).  144 
 145 
Raman spectroscopy 146 
A Renishaw ‘inVia’ Raman microscope (Renishaw plc, Wotton-under-Edge, UK) was used in this 147 
study. The spectra of femoral and calvarial osteoblasts after 21 days in culture were analyzed using a 148 
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785-nm diode laser (100mW sample power). The laser beam was focused through a water immersion 149 
x60/1.2NA objective lens (working distance: 0.27mm) while the Raman signal was acquired using a 150 
600-lines/mm diffraction grating centered between 857 and 1231 cm-1 and 2s CCD exposure time. The 151 
spectra were recorded at a resolution of ~1-2 cm-1.  152 
 153 
Mechanical stimulation 154 
Mechanical stimulation of femoral and calvarial osteoblasts was conducted as previously described 22. 155 
Cells were seeded on to the top of one side of calcium phosphate monetite scaffolds at a density of 156 
1.5×105 in 70 µl of media and allowed to attach for 30 min. The scaffold was then turned and the same 157 
number of cells were seeded on to the top of the other side and left undisturbed for a further 30 min for 158 
the cells to attach. Normal growth media was then carefully added to the culture plate and the 159 
cell/scaffold was incubated at 37°C in a humidified 5% CO2:95% air atmosphere for 48 h prior to 160 
stimulation. Mechanical loading was performed using a BOSE bioreactor (ElectroForce BioDynamic 161 
test instrument; Bose) equipped with 200N load cell. Seeded scaffolds were positioned between two 162 
loading plates inside the bioreactor chamber and loaded in the diametral compression mode by a 163 
pulsating compressive force of 5.5±4.5 N at a frequency of 0.1 Hz 22. The corresponding head 164 
displacement was 0.5–50 µm. The test was performed in load control and the evolution of the head 165 
displacement versus the pulsating compressive force was recorded by the bioreactor software 166 
(WinTest® controls). The stress distribution in the disk was analytically evaluated by the Timoshenko 167 
model 23.  168 
 169 
qRT-PCR analysis 170 
Total RNA was extracted using TRI reagent (Ambion, Warrington, UK) and Phase Lock Gel Heavy 171 
tubes (5 prime, VWR, Leicestershire, UK) according to the manufacturer’s instructions. RNA purity 172 
and quantity was assessed by Nanodrop (Fisher Scientific) (A260/A280 1.8-2 was considered suitable for 173 
further analysis), possible contaminating DNA was removed and cDNA prepared from 1 µg RNA 174 
using QuantiTect Reverse Transcription Kit (Qiagen, West Sussex, UK) according to the 175 
manufacturer’s instructions. qRT-PCR was performed on a Mx3000P real time PCR as described 176 
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previously 19. For TaqMan based analysis primers and probes were purchased from Invitrogen and for 177 
Sybr green qPCR the primers and sequences are listed in Table 1. EIF4A2 was used as a housekeeping 178 
control.  179 
 180 
Cell viability assay 181 
Cell doubling and viability (DNA synthesis) was assessed by measuring 5-ethynyl-2′ -deoxyuridine 182 
(EdU) DNA incorporation using the Click-iT EdU Alexa Fluor 647 cell proliferation assay kit 183 
(Invitrogen) and by MTS (CellTiter 96 AQueous solution cell proliferation assay; Promega, 184 
Southampton, UK) calorimetric assay following manufacturer instruction respectively. For EdU DNA 185 
incorporation assay, cells were treated with EdU at 10 µg/ml for 48 hrs, harvested by trypsinization, 186 
washed in PBS/1% BSA and fixed with Click-iT fixative. The cells were then permeabilized using 187 
saponin-based permeabilization reagent, treated with the Click-iT EdU reaction cocktail in the dark 188 
and washed with saponin-based permeabilization reagent. The number of EdU-positive cells was 189 
determined using a FACS-Canto II flow cytometer, and data analysis was performed using DIVA 190 
software (Becton Dickinson Biosciences, San Jose, CA).  191 
 192 
Alkaline phosphatase (ALP) activity assay 193 
Alkaline phosphatase (ALP) activity was determined by an assay based on the hydrolysis of p-194 
nitrophenylphosphate to p-nitrophenol (Sigma-Aldrich). Cells were washed with PBS, and 100 µl 195 
substrate solution was added to each well. After 20 minutes in the dark, the reaction was stopped and 196 
absorbance (405 nm) was read on a spectrophotometer. ALP activity was normalized to cell number 197 
by MTS assay (Promega). 198 
 199 
siRNA transfection and ERE reporter assay  200 
siRNA against Rerg, scrambled siRNA and Cignal Reporter assay (Qiagen, West Sussex, UK) were 201 
performed according to the manufacturer’s instructions. Femoral or calvarial osteoblasts were seeded 202 
at 4 × 104 cells/cm and co-transfected with 150ng of reporter construct and siRNA (final concentration 203 
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of 10nM) in 100 µl of Opti-MEM serum free media containing 2 µl of Attractene transfection reagent. 204 
After 48hrs incubation, luciferase activity was determined using the Dual-Luciferase Reporter assay 205 
system (Promega), according to the manufacturer's instructions.  206 
 207 
 208 
Data Analysis  209 
Statistical comparisons between means were made by one-way ANOVA (SPSS 17, SPSS) and post 210 
hoc analyses using the Tukey test to evaluate the differences among the mean values between groups. 211 
If comparisons were made only between two groups two tailed Student's t test (SPSS 16, SPSS) was 212 
used. A P-value of less than 0.05 was considered statistically significant.  213 
 214 
RESULTS 215 
Responses of femoral and calvarial cells to stimulation of differentiation 216 
Rawlinson and co-workers previously showed that osteoblasts derived from calvaria and femur exhibit 217 
a distinct local pattern of gene expression19. Here we investigated whether these cells are also distinct 218 
in their phenotypic responses to induction of osteogenesis. Cells were treated with differentiation 219 
media and changes in osteogenic gene expression and matrix mineralisation were analysed. 220 
Expression of Runx2, osteopontin (Spp1), ALPL and osteocalcin gradually increased during 221 
stimulation in both femoral and calvarial cells (Fig 1A). No significant differences were observed in 222 
the levels of induction of Runx2, ALPL or Spp1 expression between femoral and calvarial cells during 223 
stimulation compared to unstimulated cells at any time point. However, osteocalcin expression was 224 
increased in femoral compared to calvarial cells (more than 1600 fold higher) at late stages of culture 225 
(21D) (Fig 1A).   s shown in Figure 1A right panel, when each of the 3 cell lines were examined 226 
individually we observed a dramatically higher level of osteocalcin expression in femoral cells 227 
compared to calvarial cells. However, due to variation in differentiation capacity between each line, 228 
combination of all three lines failed to show a statistical difference even with up-regulation of 1600 229 
fold. Similarly, rapid and potent matrix mineralisation was observed in femoral cells (as early as 10 230 
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days post induction (data not shown)), whereas only negligible mineralisation was evident even after 231 
45 days of induction in calvarial cultures (Fig 1B). Furthermore, micro-Raman analysis of mineralised 232 
nodules, suggested cell dependent differences in mineral matrix composition associated with femoral 233 
compared to calvarial cells (Fig 1C).  Raman spectra of native bone and mature mineralized nodules is 234 
dominated by the PO43- peak at 959cm-1 correspond to the mineral component of bone, hydroxyapatite 235 
24
. This peak was clearly evident in femoral but not in calvarial cells, indicating lack of mineral 236 
composition in calvarial cell cultures.  237 
 238 
Responses of femoral and calvarial cells to mechanical loading. 239 
To investigate whether femoral and calvarial cells respond differently to mechanical stimulation, 240 
candidate early response genes i.e. Fosb, Junb, cFos, Fosl1, Ccl2 and Anx2a, which have been 241 
previously shown by our group and others to be stimulated in response to mechanical loading, were 242 
analysed in calvarial and femoral osteoblasts following a pulsating compressive force of 5.5±4.5 N 243 
(0.2% strain) for a period of 2 hours as described previously 22,25. As shown in Figure 2, mechanical 244 
stimulation resulted in the induction of the expression of Ccl2 and Anx2a  in femoral osteoblasts, but 245 
remained unchanged in calvarial cells in the same experiments. A similar trend was evident for Fosl1 246 
and cFos but statistical significance was not reached due to the previously mentioned variation in 247 
responses by different primary cell lines. Expression of Fosb and Junb remained unchanged in both 248 
femoral and calvarial cells (data not shown).   249 
 250 
Differences in responses of femoral and calvarial cells to induction of proliferation and ALP 251 
activity by estrogen and growth factors. 252 
To investigate whether femoral and calvarial cells respond differently to major extracellular stimuli, 253 
cells were treated with estrogen (17β-estradiol), Wnt3a, BMP2, FGF-2 or PDGF-BB and the effects on 254 
proliferation and ALP activity were assessed. Estrogen had no significant effect on either femoral or 255 
calvarial cells (Fig 3A). Similarly, we were unable to observe any stimulatory effect in presence of 256 
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BMP2 and Wnt3a (Fig 3B). Disparities between our findings and others could be due to culture 257 
conditions. Most studies were conducted in presence of osteogenic media or other stimulus in 258 
combination with BMP2 or Wnt3a, while we treated the cells in absence of any other factors. On the 259 
other hand both FGF-2 and PDGF-BB significantly stimulated calvarial cell proliferation over 260 
controls, while only a minor effect was observed on femoral cell proliferation (Fig 3B). FGF-2 was 261 
significantly inhibitory for ALP activity in both femoral and calvarial cells (Fig 3B). Since no 262 
significant effect was observed following treatment with estrogen, we further investigated the role of 263 
estrogen signalling on function of femoral and calvarial cells by blocking the estrogen receptors (ER) 264 
signalling using a selective antagonist of ER (ICI 182,780) during proliferation and induction of 265 
osteogenesis of both osteoblast cultures. Similar to stimulation studies using estrogen, no significant 266 
effect was observed on proliferation in response of either femoral or calvarial cells when ER were 267 
inhibited by ICI 182,780  and also ICI did not have any effect on FGF-2 or PDGF-BB induced cell 268 
proliferation or ALP activity (Fig 3C). The differentiation capacity of the either femoral or calvarial 269 
osteoblasts also remained unchanged in presence of ICI 182,780, showing a similar gene expression 270 
profile when stimulated by either differentiation media alone or with BMP2 (Fig 3D). Similarly, ICI 271 
182,780 had no effect on ALP activity of femoral and calvarial cells either in normal growth media or 272 
when stimulated in presence of Wnt3a, BMP2, FGF-2 or PDGF-BB (Fig 3C). 273 
 274 
Expression of ERα and ERß estrogen receptors and estrogen receptor co-activators SRC-1, -2 275 
and -3, and receptor co-repressors during differentiation of femoral and calvarial cells. 276 
Since both agonists (17β-estradiol) and antagonists (ICI 182,780) failed to elicit a response in femoral 277 
and calvarial cells we investigated possible intracellular regulation of ER. ER have been shown to 278 
have ligand-independent activity, involving receptor co-activators and receptor co-repressors. We 279 
therefore studied expression of ERα and ERß estrogen receptors, estrogen receptor co-activators Ncoa-280 
1, -2 and -3, and receptor co-repressors Ncor 1-2 and repressor of estrogen receptor activity (REA) 281 
during osteogenic maturation of the cells (Fig 4). REA expression was significantly higher in femoral 282 
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compared to calvarial cells and remained unchanged during maturation. Expression of the other 283 
receptor co-repressors was elevated at day 21 of stimulation in femoral compared to calvarial during 284 
the maturation and mineralisation period (Fig 4A-B), whereas expression levels of co-activators cells 285 
remained relatively unchanged between femoral and calvarial cells (Fig 4B). Interestingly expression 286 
of ERα was low at mRNA level and remained at an undetectable level during the course of the study. 287 
ERß expression was higher in unstimulated femoral compared to calvarial osteoblasts (Fig. 5A). 288 
However, ERß expression was significantly reduced when osteogenesis was induced in both calvarial 289 
and femoral cells and remained low to the late stage of mineralisation (21 days) (Fig 5C).   290 
 291 
Role of Rerg in femoral and calvarial cells. 292 
We also investigated the Ras-related and estrogen-regulated growth-inhibitor (Rerg) which has been 293 
suggested as an estrogen responsive gene26.  Rerg was differentially expressed in calvarial cells 294 
compared with femoral cells with basal Rerg expression being 1200 fold greater in calvarial than 295 
femoral osteoblasts (Fig 5A-B). However, upon osteogenic induction Rerg expression was 296 
dramatically increased in femoral cells reaching a maximum of 64-fold when compared with 297 
unstimulated cells in every line examined (Fig 5C).  Expression of Rerg in calvarial osteoblasts was 298 
reduced following osteogenic stimulation although this was not statistically significant (Fig 5C). 299 
Therefore, to determine possible role for Rerg in regulation of estrogen signalling between femoral 300 
and calvarial cells, we analysed the effect of siRNA knock down of Rerg on transcriptional activity 301 
down-stream of estrogen signalling using an ERE luciferase reporter assay. Interestingly, Rerg knock 302 
down resulted in significant reduction in ERE luciferase activity in calvarial but not in femoral 303 
osteoblasts (Fig 6B). These results suggest Rerg may play a site-specific role in regulating estrogen 304 
signalling in calvarial osteoblasts selectively.  305 
306 
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Discussion 307 
It is well documented that bones of the skull tend to be resistant to osteoporosis with previous studies 308 
investigating differences in characteristics between susceptible long bones and resistant skull bones 309 
12,27,28
.  However, the idea that this may be due to differences in the action of osteoblasts from these 310 
sites has not been extensively investigated. In our previous study we demonstrated that the genes 311 
associated with bone mass and mineral density are differentially expressed in functionally distinct 312 
skeletal sites 19. Here, we report that osteoblasts derived from skull and long bones are also 313 
functionally distinct. We observed that osteoblasts derived from mature calvariae have a significantly 314 
lower ability for accumulation of mineralised matrix compared with femoral osteoblasts when exposed 315 
to osteogenic induction medium containing dexamethasone, ascorbic acid and β-glycerophosphate. 316 
They were unable to produce any mineralisation by 21 days and only negligible amounts by day 45 317 
and is consistent with previously observed findings for adult-derived calvarial osteoblasts. Raman 318 
spectroscopy analysis of mineralised nodules further revealed that only mineral deposited by femoral 319 
osteoblasts produced a peak near 960 cm-1 which corresponds to the mineral component of bone 320 
hydroxyapatite 29. To find out the reason behind this observation we carried out mRNA expression 321 
analysis for genes involved in osteogenesis. As with previous studies indicating the involvement of 322 
Runx2 in both femoral and calvarial cells, a similar expression pattern was observed in both cell types 323 
here30. However, osteocalcin expression was significantly induced in femoral compared to calvarial 324 
cells at late stage of 21 days. Osteocalcin is suggested to be involved in bone mineralisation and 325 
formation of hydroxyapatite and therefore a higher level of osteocalcin expression seen in femoral 326 
osteoblasts could be associated with potent mineralisation ability of these cells 31. Our observations are 327 
also in line with the previous study showing differences in protein composition of flat and long bones, 328 
suggesting functional differences in formation, resorption, and mechanical properties of these bone 329 
types12. In contrast, a recent study has shown no differences between adult mouse-derived calvarial 330 
and femoral osteoblastic proliferation rates, mineralisation capacity and levels of osteogenic gene 331 
expression16. Among other characteristics that separate these bones is the difference in response to 332 
mechanical loading. It is known that maintenance of BMD in long bones is dependent on mechanical 333 
loading and osteoblasts derived from these sites are responsive to mechanical loading, while BMD in 334 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 14
the skull remains high in absence of loading and calvarial cells are shown to be insensitive to 335 
mechanical loading 32,33. However, a contrasting observation has been reported showing that 336 
compressive forces upregulate the expression of osteogenic genes Bmp2, Runx2 and Smad5 and 337 
promote osteogenesis of calvarial osteoblasts 34. This study was however conducted on newborn 338 
calvarial cells which could probably account for the disparities seen between data. Here we confirm 339 
the idea supporting the lack of response by calvarial cells and show that only osteoblasts derived from 340 
femur are sensitive to mechanical loading, showing elevated expression of early genes associated with 341 
mechanical stimulation 25.  342 
The calvarial bone is known to be insensitive to post-menopausal hormonal changes and osteoporosis. 343 
Osteoblasts in vitro are known to be estrogen responsive and classically, stimulation with 17ß-344 
estradiol has been shown to upregulate osteoblast proliferation and expression of differentiation 345 
markers35-38. However more recent experiments have demonstrated a more complex set of distinct 346 
responses to estrogen stimulation (both stimulation and inhibition) which are dependent on expression 347 
of ER and which may alter markedly according to the stage of cell differentiation 39,40.  Almeida and 348 
co-workers demonstrated that the effects of estrogen signalling are due to activity in osteoblast 349 
progenitors but not in mature osteoblasts or osteocytes 40. In line with this we observed no stimulatory 350 
effect on mature osteoblasts from either calvarial or femoral bones by estrogen or any inhibitory effect 351 
in presence of ER antagonist (ICI 182,780).  352 
Interestingly a distinctive response in proliferation and ALP activity was observed when cells were 353 
treated with FGF-2 or PDGF-BB, suggesting possible proliferative involvement of these growth 354 
factors in calvarial but not femoral osteoblasts. Since both agonist (estrogen) and antagonist (ICI 355 
182,780) treatment failed to elicit a response in femoral and calvarial cells we investigated the possible 356 
intracellular involvement of receptor co-activators and receptor co-repressors of ER. The most 357 
significant difference was shown by Rerg which has been suggested to be an estrogen responsive gene. 358 
Interestingly, in previous work we also found that Rerg was preferentially expressed in calvarial cells 359 
in our microarrays19.  As yet there is no information about the involvement of Rerg in regulating 360 
osteoblastic responses to estrogen.  Here, using qRT-PCR analysis we showed that basal Rerg 361 
expression was 1200 fold greater in calvarial than femoral osteoblasts. Upon osteogenic induction 362 
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Rerg expression was however significantly increased in femoral cells reaching a maximum of 64-fold 363 
when compared with unstimulated cells. In contrast, osteogenic stimulation had an inhibitory effect on 364 
the expression of Rerg in calvarial osteoblasts, Depletion of Rerg results in significant reduction in 365 
ERE luciferase activity in calvarial but not in femoral osteoblasts. Taken together these data suggest a 366 
specific role for Rerg in regulation of estrogen signalling and function of calvarial, but not femoral 367 
osteoblasts. 368 
 369 
In summary, the results demonstrate cell autonomous functional differences between calvarial and 370 
femoral osteoblasts in vitro.  In particular the results demonstrate that femoral osteoblasts specifically 371 
express immediate-early response genes Fosl1, Ccl2, Anx2a and cFos following mechanical loading 372 
and this could in part responsible for site specific differences. A recent study has also shown distinct 373 
mechanosensitivities and architectural differences between osteocytes in calvarial and long 374 
bones14. Femoral cells also showed markedly elevated levels of estrogen receptor-ß (ERß).  In 375 
contrast, calvarial cells specifically express the Rerg gene which is implicated in regulation of the 376 
estrogen response element.  It is possible that Rerg is acting to maintain estrogen responses in the 377 
absence of ligand receptor binding in calvarial cells whereas femoral cells may be dependent on ERß 378 
ligand binding, although further work is required to investigate this. Overall these phenotypic 379 
functional differences are consistent with cell autonomous differences in regionally defined 380 
osteoblasts being responsible for variations in susceptibility to osteoporotic changes and suggest 381 
possible targeting of the estrogen signalling pathway as a future therapeutic opportunity.   382 
 383 
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FIGURE LEGENDS 
Figure 1. Femoral and calvarial osteoblast responses to osteogenic stimulation and 
mineralisation. Femoral and calvarial osteoblasts were cultured for indicated times in osteogenic 
medium. (A) mRNA expression of osteogenic markers Runx2, Osteopontin (SSP1), ALPL and 
Osteocalcin were quantified by quantitative-reverse transcription polymerase chain reaction (qRT-
PCR) (n=3). EIF4A2 was used as a housekeeping control and expression of the gene of interest is 
shown as relative expression to cells at day 0. Osteocalcin expression in individual line is shown in the 
right panel. (B) The ability of each cell to form matrix mineralisation was determined following 
Alizarin Red staining (at least 3 experiments per individual cell line). (C) Raman spectra of the 
femoral (a-red line) and calvarial (b-black line) osteoblasts after 21 days in culture. The Raman 
spectrum of the femoral osteoblasts was characterised by the presence of a peak near 960cm-1 which 
correspond to the symmetric stretching vibration of P–O in PO43- tetrahedra of hydroxyapatite (HA) 
crystals.  
 
Figure 2. Femoral and calvarial osteoblast responses to mechanical stimulation.  Mechanical 
loading was performed using a BOSE bioreactor (ElectroForce BioDynamic test instrument; Bose) 
with a diametral compression mode by a pulsating compressive force of 5.5±4.5 N at a frequency of 
0.1 Hz giving a corresponding head displacement of 0.5–50 µm.  mRNA expression for Fosl1, Ccl2, 
Anx2a and cFos in femoral and calvarial osteoblasts subjected to mechanical strain was determined by 
qRT-PCR. Data is shown as mean ± SEM from at least five experiments.  EIF4A2 was used as a 
housekeeping control and relative quantitative expression was calculated as a ratio of un-loaded cells 
that was assigned a value of 1. T test was used for statistical analysis between loaded and un-loaded 
cells (p<0.05*). 
 
Figure 3. Differences in responses of femoral and calvarial cells to growth factors and estrogen 
signalling. (A) Effect of estrogen signalling was assessed on proliferation of calvarial and femoral 
osteoblasts in presence of 17β-estradiol, using EdU assay. Cells were serum deprived (1%) for 12 hrs 
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and subsequently cultured in presence of 17β-estradiol (E) (10 nM). The proliferation rate was 
determined by analyzing the proportion of cells that incorporated EdU following 48 hrs of incubation 
using flow cytometry.  Data shown are representative of three separate experiments. All experiments 
involving 17β-estradiol stimulation were performed with charcoal stripped serum and phenol red-free 
medium. (B) Calvarial and femoral cells were cultured with or without Wnt3a (50ng/ml), BMP2 
(100ng/ml), FGF-2 (10ng/ml) or PDGF-BB (10ng/ml) and cell proliferation and ALP activity was 
assessed after 7 days of culture (Mean ± SEM of three experimental groups). (C&D) Effect of 
inhibition of ER signalling on proliferation and differentiation of osteoblasts. Cells were treated with 
an ER antagonist (ICI 182,780) (500nM) (C) proliferation and ALP activity was assessed after 7 days 
of culture and (D) differentiation was assessed by analysing the expression of osteogenic markers 
Runx2, Osteopontin (SSP1) and Osteocalcin after 21 days of culture. EIF4A2 was used as a 
housekeeping control and relative quantitative expression was calculated as a ratio of un-treated cells 
that was assigned a value of 1. p <0.01##, <0.001### when compared with untreated control (C). 
p<0.05*, <0.01**, <0.001*** when compared calvarial to femoral osteoblasts following the same 
treatment. 
 
Figure 4. Expression of estrogen receptor co-activators and receptor co-repressors during 
induction of osteogenesis of femoral and calvarial osteoblasts. Expression of estrogen receptor co-
activators (Ncoa1-3) and receptor co-repressors (Ncor1-2 and REA) was quantified. (A) In femoral and 
calvarial of untreated cells. Expression of each gene was calculated and normalised relative to 
EIF4A2 (Mean ± SEM of three experiments, p<0.001***). (B) During 21 days of differentiation in 
osteogenic culture. EIF4A2 was used as a housekeeping control and relative quantitative expression 
was calculated as a ratio of cells at day 0 that was assigned a value of 1.  
 
Figure 5. ESRβ and Rerg expression during induction of osteogenesis of femoral and calvarial 
osteoblasts.  (A)  Expression of ESRβ and Rerg were quantified and normalised relative to EIF4A2 in 
untreated femoral and calvarial cells (Mean ± SEM of three experiments). (B) Expression of Rerg in 
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individual lines. (C) ESRβ and Rerg expression over 21 days of differentiation in osteogenic cultures. 
(Mean ± SEM of three experiments).  
 
Figure 6. Effect of Rerg knockdown on estrogen signalling in femoral and calvarial osteoblasts.  
Cells were co-transfected with a Cingal dual-luciferase-based ERE reporter assay, Rerg siRNA and 
scramble control siRNA and the alteration in ERE promoter activity by Rerg knockdown was assessed 
after 48h. The activity was normalised to Renilla luciferase that acts as an internal control for 
transfection efficiencies and calculated as percentage of induction compared with cell transfected with 
control scramble siRNA. (Mean ± SEM of three experiments, p<0.001***). 
 
 
 
 
 
 
Table 1. List of primers and sequences for Sybr green based qRT-PCR.  
Genes Forward (5’ to 3’) Reverse (5’ to 3’) 
Annexin A2 TCTGACTAACCGCAGCAATG ACCAGACAAGGCCGACTTC 
CCL2 CAAGAGAATCACCAGCAGCA CTGGACCCATTCCTTATTGG 
cFOS GGGAGTGGTGAAGACCATGT CGGATTCTCCGTTTCTCTTC 
EIF4A2 TGTGCAACAAGTGTCCTTGG ACCTTTCCTCCCAAATCGAC 
ESRa CACCAGGTGCCCTACTACCT CGTCGATTGTCAGAATTGGA 
Fosl1 AGAGCGGAACAAGCTAGCAG CCGATTTCTCATCCTCCAAC 
Junb CAGTTACTCCCCAGCCTCTG GCATGTGGGAGGTAGCTGAT 
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Highlights 
 
• Adult-derived skull and limb osteoblasts exhibit phenotypic heterogeneity 
• Skull osteoblasts have reduced mineralisation capacity and loading responsiveness 
• Estrogen responsive gene Rerg selectively highly expressed in skull osteoblasts 
• Rerg gene silencing reduced estrogen pathway signalling in skull osteoblasts only 
 
